Evidence map›Paper›PMID 39431801›Full record

ArticleJournal of visualized experiments : JoVE2024

Spatiotemporal Control of Protein Activity through Optogenetic Allosteric Regulation.

Trisha Bansal, Nicholas Lechinsky, Andrei V Karginov

Abstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Trisha BansalDepartment of Pharmacology and Regenerative Medicine, University of Illinois at Chicago.
Nicholas LechinskyDepartment of Pharmacology and Regenerative Medicine, University of Illinois at Chicago.
Andrei V KarginovDepartment of Pharmacology and Regenerative Medicine, University of Illinois at Chicago; karginov@uic.edu.

Funding

Synthetic Biology and Optogenetics CoreP01HL151327 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI REHMAN, JALEES · 2021 to 2025
$11.8M
Regulation of endothelial cell invasion, migration and cell junction plasticityR35GM145318 · NIGMS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI ANDREI V KARGINOV · 2022 to 2026
$2.2M
Vascular Biology, Signaling and Therapeutics training programT32HL144459 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI KITAJEWSKI, JAN K., WARY, KISHORE K · 2019 to 2023
$1.6M
Optogenetic Control of Tumor Initiation and Tumor Progression in vivoR33CA258012 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI KARGINOV, ANDREI V, REHMAN, JALEES · 2022 to 2024
$1.2M
NCI NIH HHS R33 CA258012NHLBI NIH HHS P01 HL151327NHLBI NIH HHS T32 HL144459NIGMS NIH HHS R35 GM145318
6 · The paper itself

Abstract

Optogenetics offers the potential for mimicking complex spatiotemporal control of enzyme activity down to a subcellular resolution. However, most optogenetic approaches often face significant challenges in integrating multiple capabilities in a single tool applicable to a wide range of target proteins. Achieving precise control over ON/OFF kinetics, ensuring minimum leakiness in the dark, and demonstrating efficient performance in mammalian cells with subcellular precision are some of the most common challenges faced in this field. A promising solution lies in the application of rationally designed light-sensitive domains to allosterically control protein activity. Using that strategy, we generated an optogenetic method combining all the desired features. The approach involves the incorporation of the Light-regulated allosteric switch module (LightR) in the target protein to regulate enzyme activity using blue (465 nm) light. The LightR domain is generated by linking two Vivid (VVD) photoreceptor domains, creating a light-sensitive clamp that can be incorporated into a small flexible loop within the catalytic domain of an enzyme. In its dark state, LightR clamp is open, thus distorting the enzyme's catalytic domain and inactivating it. Upon exposure to blue light, the LightR domain closes and restores the catalytic domain's structure and enzyme activity. In this manuscript, we discuss design strategies to generate a light-regulated protein kinase and demonstrate its control by blue light, reversibility, kinetics, and precise regulation at the subcellular level, enabling tight spatiotemporal precision. Utilizing Src tyrosine kinase as a model, we showcase a protocol for effectively regulating LightR-Src kinase activity. We also demonstrate LightR applicability across different enzyme classes, expanding the utility of the tool system in addressing mechanistic questions of signaling pathways in different diseases.

Indexed as

OptogeneticsAllosteric RegulationHumans

Identifiers

PMID39431801
PMCPMC12199233

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.